Publications by authors named "Shushu Hao"

This study investigated pathogenic genes associated with non-syndromic cleft lip with or without cleft palate (NSCL/P) through transcriptome-wide association studies (TWAS). By integrating expression quantitative trait loci (eQTL) data with genome-wide association study (GWAS) data, we identified key susceptibility genes, including . Notably, the variant rs12884809 G>A was associated with an increased risk of NSCL/P by enhancing the binding of the transcription factor ELK1 to the promoter, thereby activating its expression.

View Article and Find Full Text PDF

A linear-organic-polymer-supported iridium complex Cp*Ir@P4VP, which is designed and synthesized by the coordinative immobilization of [Cp*IrCl] on poly(4-vinylpyridine), was proven to be an efficient heterogeneous autotandem catalyst for synthesizing quinazolinones via selective hydration/acceptorless dehydrogenative coupling from -aminobenzonitriles. Furthermore, the synthesized catalyst was recycled five times without an obvious decrease in the catalytic activity.

View Article and Find Full Text PDF

Diabetes mellitus (DM)-induced glucolipotoxicity is a factor strongly contributing to alveolar bone deficiency. Parathyroid hormone (PTH) has been identified as a main systemic mediator to balance physiological calcium in bone. This study aimed to uncover PTH's potential role in ameliorating the osteogenic capacity of human bone marrow mesenchymal stem cells (HBMSCs) against glucolipotoxicity.

View Article and Find Full Text PDF
Article Synopsis
  • Bone volume inadequacy is a growing issue affecting dental implant success, and human bone marrow mesenchymal stem cells (HBMSCs) play a crucial role in bone regeneration.
  • The study focused on the long noncoding RNA H19 and its influence on osteogenesis (bone formation) in HBMSCs driven by human amnion-derived mesenchymal stem cells (HAMSCs).
  • It was found that the presence of HAMSCs enhances HBMSCs' osteogenesis through the H19/miR-675/APC pathway, making H19 a potential target for treating bone-related diseases.
View Article and Find Full Text PDF

Human adipose-derived stem cells (HASCs) represent pluripotent cells capable of differentiating into the bone tissue. Meanwhile, human amnion-derived mesenchymal stem cells (HAMSCs) could cause mesenchymal stem cells to differentiate into the bone tissue. This work assessed the osteogenic effects exerted by HAMSCs on the potential of HASCs to form bone cells.

View Article and Find Full Text PDF